Search

everythinglearnresearchcommunity

for

Search:↓

Men with higher androgen levels may have severe COVID-19 symptoms, but those on antiandrogen therapy are less likely to contract the virus and have milder symptoms. Anti-androgen drugs could potentially treat COVID-19, but more research is needed.

Higher ACE2 levels in certain tissues may worsen COVID-19 in people with other health issues, especially older adults.

Fatigue is the most common symptom in both ongoing symptomatic COVID-19 and post-COVID-19 syndrome.

Reprogramming macrophages to resolve inflammation can help reduce severe COVID-19 complications.

MX1 and AR genes are linked to milder COVID-19, while TMPRSS2 increases severe risk, especially in women.

The skin conditions of Iraqi women changed during the COVID-19 pandemic, with more hair loss and skin irritation but fewer contagious skin infections.

Men with androgenetic alopecia and hypertension may experience more severe COVID-19.

Common dermatology drugs were considered but are controversial for COVID-19 treatment.

The pandemic worsened physical and mental challenges for women with PCOS.

Pulmonary delivery of cepharanthine significantly improves its effectiveness and shows promise for treating lung fibrosis linked to COVID-19.

A standardized drug development platform is essential for efficient and effective drug repurposing, especially during pandemics.

Good nutrition and essential trace elements like zinc, selenium, and iron are important for a strong immune system and reducing COVID-19 severity.

Men with male pattern baldness may be more at risk for severe COVID-19, and anti-androgen treatments could offer protection.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

COVID-19 changed dermatology by increasing telemedicine and highlighting healthcare disparities.

COVID-19 temporarily affects male reproductive health, but sperm and testosterone levels generally return to normal after three months.

COVID-19 can cause different skin symptoms that may help with early diagnosis and show how severe the disease is.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

Mice with a virus similar to COVID-19 had skin damage, but a special treatment helped repair it.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Women with PCOS are more vulnerable to severe COVID-19 and related health issues.

COVID-19 survivors may face long-term health issues affecting both mind and body.

The study concludes that long COVID recovery involves time, various treatments, and a strong patient-provider relationship.

Possible link between androgens and COVID-19 severity; more research needed.

Long-haul COVID can cause lasting symptoms affecting many body systems and may be linked to ongoing inflammation and immune system issues.

The COVID-19 pandemic led to fewer dermatology visits and changed the types of skin conditions patients experienced.

Many COVID-19 patients have long-term symptoms, especially women, but certain medications may help reduce these symptoms.

Long-COVID causes more health issues after COVID-19, varying by age, sex, and infection wave.

COVID-19 vaccination may slightly increase the risk of hair loss, but benefits outweigh this risk.

SARS-CoV-2 might infect and multiply in skin tissue, possibly aiding in its transmission.